|
1
|
Weintraub NL: Understanding abdominal
aortic aneurysm. N Engl J Med. 361:1114–1116. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kent KC: Clinical practice. Abdominal
aortic aneurysms. N Engl J Med. 371:2101–2108. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thompson RW, Liao S and Curci JA: Vascular
smooth muscle cell apoptosis in abdominal aortic aneurysms. Coron
Artery Dis. 8:623–631. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang C: MicroRNomics: A newly emerging
approach for disease biology. Physiol Genomics. 33:139–147. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Seeger T and Boon RA: MicroRNAs in
cardiovascular ageing. J Physiol. 594:2085–2094. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Small EM and Olson EN: Pervasive roles of
microRNAs in cardiovascular biology. Nature. 469:336–342. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Urbich C, Kuehbacher A and Dimmeler S:
Role of microRNAs in vascular diseases, inflammation, and
angiogenesis. Cardiovasc Res. 79:581–588. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kin K, Miyagawa S, Fukushima S, Shirakawa
Y, Torikai K, Shimamura K, Daimon T, Kawahara Y, Kuratani T and
Sawa Y: Tissue- and plasma-specific microRNA signatures for
atherosclerotic abdominal aortic aneurysm. J Am Heart Assoc.
1:e0007452012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Roderburg C, Urban GW, Bettermann K, Vucur
M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi
M, et al: Micro-RNA profiling reveals a role for miR-29 in human
and murine liver fibrosis. Hepatology. 53:209–218. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qin W, Chung AC, Huang XR, Meng XM, Hui
DS, Yu CM, Sung JJ and Lan HY: TGF-β/Smad3 signaling promotes renal
fibrosis by inhibiting miR-29. J Am Soc Nephrol. 22:1462–1474.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Van Rooij E, Sutherland LB, Thatcher JE,
DiMaio JM, Naseem RH, Marshall WS, Hill JA and Olson EN:
Dysregulation of microRNAs after myocardial infarction reveals a
role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA.
105:13027–13032. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
De Paepe A, Nuytinck L, Hausser I,
Anton-Lamprecht I and Naeyaert JM: Mutations in the COL5A1 gene are
causal in the Ehlers-Danlos syndromes I and II. Am J Hum Genet.
60:547–554. 1997.PubMed/NCBI
|
|
13
|
Rahkonen O, Su M, Hakovirta H, Koskivirta
I, Hormuzdi SG, Vuorio E, Bornstein P and Penttinen R: Mice with a
deletion in the first intron of the Col1a1 gene develop
age-dependent aortic dissection and rupture. Circ Res. 94:83–90.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Menashi S, Campa JS, Greenhalgh RM and
Powell JT: Collagen in abdominal aortic aneurysm: Typing, content,
and degradation. J Vasc Surg. 6:578–582. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rizzo RJ, McCarthy WJ, Dixit SN, Lilly MP,
Shively VP, Flinn WR and Yao JS: Collagen types and matrix protein
content in human abdominal aortic aneurysms. J Vasc Surg.
10:365–373. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen KC, Wang YS, Hu CY, Chang WC, Liao
YC, Dai CY and Juo SH: OxLDL up-regulates microRNA-29b, leading to
epigenetic modifications of MMP-2/MMP-9 genes: A novel mechanism
for cardiovascular diseases. FASEB J. 25:1718–1728. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Funk CD: Prostaglandins and leukotrienes:
Advances in eicosanoid biology. Science. 294:1871–1875. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Walton LJ, Franklin IJ, Bayston T, Brown
LC, Greenhalgh RM, Taylor GW and Powell JT: Inhibition of
prostaglandin E2 synthesis in abdominal aortic aneurysms:
Implications for smooth muscle cell viability, inflammatory
processes, and the expansion of abdominal aortic aneurysms.
Circulation. 100:48–54. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Diaz A, Munoz E, Johnston R, Korn JH and
Jimenez SA: Regulation of human lung fibroblast alpha 1(I)
procollagen gene expression by tumor necrosis factor alpha,
interleukin-1 beta, and prostaglandin E2. J Biol Chem.
268:10364–10371. 1993.PubMed/NCBI
|
|
20
|
Holmes DR, Wester W, Thompson RW and
Reilly JM: Prostaglandin E2 synthesis and cyclooxygenase expression
in abdominal aortic aneurysms. J Vasc Surg. 25:810–815. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yokoyama U, Ishiwata R, Jin MH, Kato Y,
Suzuki O, Jin H, Ichikawa Y, Kumagaya S, Katayama Y, Fujita T, et
al: Inhibition of EP4 signaling attenuates aortic aneurysm
formation. PLoS One. 7:e367242012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gonzalez P, Luna C, Li G, Qiu J and
Epstein DL: miR-29 is induced by prostaglandin E and forms negative
feedback loops with the Wnt and TGFbeta pathways in human
trabecular meshwork cells. Invest Ophthalmol Vis Sci.
51:32102010.PubMed/NCBI
|
|
23
|
Fang J, Hao Q, Liu L, Li Y, Wu J, Huo X
and Zhu Y: Epigenetic changes mediated by microRNA miR29 activate
cyclooxygenase 2 and lambda-1 interferon production during viral
infection. J Virol. 86:1010–1020. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiao J, Meng XM, Huang XR, Chung AC, Feng
YL, Hui DS, Yu CM, Sung JJ and Lan HY: miR-29 inhibits
bleomycin-induced pulmonary fibrosis in mice. Mol Ther.
20:1251–1260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y, Wu L, Wang Y, Zhang M, Li L, Zhu
D, Li X, Gu H, Zhang CY and Zen K: Protective role of
estrogen-induced miRNA-29 expression in carbon
tetrachloride-induced mouse liver injury. J Biol Chem.
287:14851–14862. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang B, Komers R, Carew R, Winbanks CE, Xu
B, Herman-Edelstein M, Koh P, Thomas M, Jandeleit-Dahm K,
Gregorevic P, et al: Suppression of microRNA-29 expression by
TGF-β1 promotes collagen expression and renal fibrosis. J Am Soc
Nephrol. 23:252–265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maurer B, Stanczyk J, Jüngel A,
Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE,
Michel BA, Distler JH, et al: MicroRNA-29, a key regulator of
collagen expression in systemic sclerosis. Arthritis Rheum.
62:1733–1743. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maegdefessel L, Azuma J, Toh R, Merk DR,
Deng A, Chin JT, Raaz U, Schoelmerich AM, Raiesdana A, Leeper NJ,
et al: Inhibition of microRNA-29b reduces murine abdominal aortic
aneurysm development. J Clin Invest. 122:497–506. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sakalihasan N, Heyeres A, Nusgens BV,
Limet R and Lapière CM: Modifications of the extracellular matrix
of aneurysmal abdominal aortas as a function of their size. Eur J
Vasc Surg. 7:633–637. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Martufi G, Satriano A, Moore RD, Vorp DA
and Di Martino ES: Local quantification of wall thickness and
intraluminal thrombus offer insight into the mechanical properties
of the aneurysmal aorta. Ann Biomed Eng. 43:1759–1771. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hance KA, Tataria M, Ziporin SJ, Lee JK
and Thompson RW: Monocyte chemotactic activity in human abdominal
aortic aneurysms: Role of elastin degradation peptides and the
67-kD cell surface elastin receptor. J Vasc Surg. 35:254–261. 2002.
View Article : Google Scholar : PubMed/NCBI
|
